Royalty Pharma Down Nearly 6%, on Pace for Largest Percent Decrease Since March 2025 -- Data Talk
Dow Jones2026/09/08 17:26Royalty Pharma Plc Class A (RPRX) is currently at $60.20, down $3.76 or 5.88%
--Would be lowest close since Aug. 18, 2026, when it closed at $59.69
--On pace for largest percent decrease since March 26, 2025, when it fell 6.52%
--Snaps a five-day winning streak
--Down 1.97% month-to-date
--Up 55.8% year-to-date
--Down 5.88% from its all-time closing high of $63.96 on Sept. 4, 2026
--Up 64.93% from 52 weeks ago (Sept. 9, 2025), when it closed at $36.50
--Down 5.88% from its 52-week closing high of $63.96 on Sept. 4, 2026
--Up 72.49% from its 52-week closing low of $34.90 on Sept. 25, 2025
--Traded as low as $58.63; lowest intraday level since Aug. 17, 2026, when it hit $58.18
--Down 8.33% at today's intraday low; largest intraday percent decrease since June 19, 2020, when it fell as much as 8.53%
All data as of 1:22:25 PM ET
Source: Dow Jones Market Data, FactSet
(END) Dow Jones Newswires
September 08, 2026 13:26 ET (17:26 GMT)
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
The three major U.S. stock indexes have risen, and the Nasdaq 100 index has turned positive.

Pfizer CEO Albert Bourla Joins Jefferies Healthcare Conference Discussion
GTA 6 Prepares for Star-Studded Miami Launch as Wall Street Eyes 37% Stock Rally
